OrbiMed’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.82M Buy
+387,000
New +$2.01M 0.03% 117

Other funds holding UNCY

OrbiMed's UNCY Position: Q3 2026 in Review

OrbiMed opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 387,000 shares worth $1.82M. The stake represents 0.03% of the portfolio and ranks #117 among its holdings.

90 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • OrbiMed held 387,000 shares of Unicycive Therapeutics worth $1.82M as of Q3 2026.
  • Unicycive Therapeutics was a new OrbiMed position in Q3 2026.
  • Unicycive Therapeutics made up 0.03% of OrbiMed's portfolio in Q3 2026, its #117 holding.
  • 90 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.